Login

Dr. Peter Suzdak, CEO of Rexahn Pharmaceuticals 00:00:00

Share On Facebook Share On Twitter

Corporate Profile interviews Dr. Peter Suzdak, CEO of Rexahn Pharmaceuticals (RNN)

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
HealthBeacon PLC co-founder and CEO, Jim Joyce, joined Proactive's Stephen Gunnion to discuss the company's developments.
00:10:00
How Three Key Industry Shifts Are Driving Success for Four High-Quality Holdings at Royce Investment Partners
00:10:00
Unigold Inc.: Exploring the Dominican Republic's Gold Potential
00:10:00
Seeking viewer input on future visions, as discussed by a construction industry leader | Keiichi Yoshii, CEO , Daiwa house industry co.
00:10:00
Manas Resources Explores Growth Opportunities at One-to-One Conference in Cape Town
00:10:00
Q4 2024 Earnings Presentation & Conference Call: Financial Insights & Growth Indicators | Ty R. Silberhorn - CEO of Apogee Enterprises, Inc.
00:00:00
ReNeuron focus on new clinical trials - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
Lim Chow Kiat, GIC CEO, discussed GIC's sustainable investment strategies and focus on "green" tech companies in an interview on 'Squawk on the Street.'
00:00:00
aims to be an innovative drug discovery and development company - Michael A. Martino, Chief Executive Officer, Ampio Pharmaceuticals Inc
00:10:00
The Plunge in Oil Prices: Causes, Opportunities, and Risks | James M. Russo, Founder , Altrius Capital Management.
00:10:00
Interview with Kevin McElligott, Managing Director Australia at Franco-Nevada
00:10:00
Talisman Mining: Unveiling High-Grade Potential in Western Australia

© 2017 - Neuhu+